Transitions makes available polycarbonate performance sunwear

Article

KBco and Transitions Optical, Inc. have announced the availability of a polycarbonate performance sun lens called Xperio, which adapt to changing light conditions, improve contrast and reduce blinding glare from sunlight reflected off the surface of objects, water or snow making them ideal for outdoor activities such as fishing and water activities, running, hiking and mountain biking.

Pinellas Park, FL-KBco and Transitions Optical, Inc. have announced the availability of a polycarbonate performance sun lens called Xperio, which adapt to changing light conditions, improve contrast and reduce blinding glare from sunlight reflected off the surface of objects, water or snow making them ideal for outdoor activities such as fishing and water activities, running, hiking and mountain biking. 

Polycarbonate lenses are ideal for high-impact sports as they are made from a tough, lightweight plastic. The lenses are thinner than most plastic lenses and are impact resistant, while still protecting against harmful UV rays by blocking 100 percent of UVA and UVB rays.

Xperio Transitions performance lenses are available in single vision prescriptions ranging from -10.00 to +6.00 in gray.

For more information: en-us.transitions.com.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.